Xiaojun Yao

54PUBLICATIONS
58CO-AUTHORS
Electrical energy transmission, networks and systemsGene and molecular therapyCheminformatics and quantitative structure-activity relationshipsProteomics and intermolecular interactions (excl. medical proteomics)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Sep 30, 2026
The SIMDA framework maps PIP2-binding sites regulating the KCNQ1 channel.

|Aug 30, 2026
Identification of New Anti-Trypanosoma brucei Leads: An Integrated CRK12-Guided Virtual Screen With Experimental Validation.

|Aug 21, 2026
A Unified Hierarchical Multiscale Fusion Framework for Drug-Target Affinity Prediction: From Benchmark Performance to Nanomolar Inhibitor Discovery.

|Sep 30, 2025
Interpretable PROTAC Degradation Prediction With Structure-Informed Deep Ternary Attention Framework.

Zhenglu Chen, Chunbin Gu, Shuoyan Tan

|Nov 02, 2024
LRRK2 Inhibitors as Promising Treatment for Parkinson's Disease.

Shuoyan Tan, Huanxiang Liu, Xiaojun Yao

|Jul 10, 2024
Identification of novel LRRK2 inhibitors by structure-based virtual screening and alchemical free energy calculation.

Shuoyan Tan, Xiaoqing Gong, Huanxiang Liu

Pageof 9

Frequent Collaborators

22 joint publications

Huanxiang Liu

5 joint publications

Tingjun Hou

4 joint publications

Jianguo Fang

4 joint publications

Yan Zhang